Which has preferable earnings and valuation, COO or ALC?

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cooper Companies $4.23B 3.42 $374.90M $1.18 62.91 Alcon $10.40B 3.33 $980M $1.66 42.21

Does the media prefer COO or ALC?

In the previous week, Cooper Companies had 14 more articles in the media than Alcon. MarketBeat recorded 16 mentions for Cooper Companies and 2 mentions for Alcon. Cooper Companies' average media sentiment score of 1.05 beat Alcon's score of 0.53 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Alcon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, ALC or DXCM?

Alcon has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.33 $980M $1.66 42.21 DexCom $4.66B 6.73 $836.30M $2.53 32.85

Is ALC or DXCM more profitable?

DexCom has a net margin of 20.12% compared to Alcon's net margin of 7.70%. DexCom's return on equity of 35.94% beat Alcon's return on equity. Company Net Margins Return on Equity Return on Assets Alcon 7.70% 7.11% 4.98% DexCom 20.12% 35.94% 14.75%

Does the media favor ALC or DXCM?

In the previous week, DexCom had 56 more articles in the media than Alcon. MarketBeat recorded 58 mentions for DexCom and 2 mentions for Alcon. DexCom's average media sentiment score of 0.83 beat Alcon's score of 0.53 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 25 Very Positive mention(s) 4 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, HCA or ALC?

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HCA Healthcare $75.60B 1.18 $6.78B $29.87 13.84 Alcon $10.40B 3.33 $980M $1.66 42.21

Is HCA or ALC more profitable?

HCA Healthcare has a net margin of 8.77% compared to Alcon's net margin of 7.70%. Alcon's return on equity of 7.11% beat HCA Healthcare's return on equity. Company Net Margins Return on Equity Return on Assets HCA Healthcare 8.77% -244.79% 11.10% Alcon 7.70% 7.11% 4.98%

Does the media refer more to HCA or ALC?

In the previous week, HCA Healthcare had 19 more articles in the media than Alcon. MarketBeat recorded 21 mentions for HCA Healthcare and 2 mentions for Alcon. HCA Healthcare's average media sentiment score of 0.76 beat Alcon's score of 0.53 indicating that HCA Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HCA Healthcare 12 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Alcon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ALC or THC?

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.33 $980M $1.66 42.21 Tenet Healthcare $22.64B 1.00 $1.41B $25.93 10.13

Does the media refer more to ALC or THC?

In the previous week, Tenet Healthcare had 10 more articles in the media than Alcon. MarketBeat recorded 12 mentions for Tenet Healthcare and 2 mentions for Alcon. Tenet Healthcare's average media sentiment score of 0.90 beat Alcon's score of 0.53 indicating that Tenet Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Tenet Healthcare 9 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, EHC or ALC?

Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Encompass Health $6.07B 2.02 $566.20M $5.99 20.59 Alcon $10.40B 3.33 $980M $1.66 42.21

Does the media refer more to EHC or ALC?

In the previous week, Encompass Health had 9 more articles in the media than Alcon. MarketBeat recorded 11 mentions for Encompass Health and 2 mentions for Alcon. Encompass Health's average media sentiment score of 1.10 beat Alcon's score of 0.53 indicating that Encompass Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Encompass Health 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alcon 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Alcon (ALC) Competitors

$70.07 -0.50 (-0.70%)

As of 10:00 AM Eastern

Compare

ALC vs. COO, DXCM, HCA, THC, and EHC

Should you buy Alcon stock or one of its competitors? MarketBeat compares Alcon with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alcon include Cooper Companies (COO), DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), and Encompass Health (EHC).

How does Alcon compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

Cooper Companies has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Alcon has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.42	$374.90M	$1.18	62.91
Alcon	$10.40B	3.33	$980M	$1.66	42.21

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Alcon	7.70%	7.11%	4.98%

Cooper Companies presently has a consensus price target of $81.36, suggesting a potential upside of 9.60%. Alcon has a consensus price target of $84.76, suggesting a potential upside of 20.96%. Given Alcon's stronger consensus rating and higher probable upside, analysts plainly believe Alcon is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 1.5% of Alcon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Cooper Companies had 14 more articles in the media than Alcon. MarketBeat recorded 16 mentions for Cooper Companies and 2 mentions for Alcon. Cooper Companies' average media sentiment score of 1.05 beat Alcon's score of 0.53 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alcon beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Alcon compare to DexCom?

Alcon (NYSE:ALC) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Alcon has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, DexCom has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

DexCom has a net margin of 20.12% compared to Alcon's net margin of 7.70%. DexCom's return on equity of 35.94% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
DexCom	20.12%	35.94%	14.75%

53.9% of Alcon shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Alcon currently has a consensus price target of $84.76, indicating a potential upside of 20.96%. DexCom has a consensus price target of $88.71, indicating a potential upside of 6.73%. Given Alcon's higher possible upside, equities research analysts plainly believe Alcon is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

In the previous week, DexCom had 56 more articles in the media than Alcon. MarketBeat recorded 58 mentions for DexCom and 2 mentions for Alcon. DexCom's average media sentiment score of 0.83 beat Alcon's score of 0.53 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	25 Very Positive mention(s)	4 Positive mention(s)	18 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Alcon has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.33	$980M	$1.66	42.21
DexCom	$4.66B	6.73	$836.30M	$2.53	32.85

Summary

DexCom beats Alcon on 12 of the 17 factors compared between the two stocks.

How does Alcon compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

HCA Healthcare has a net margin of 8.77% compared to Alcon's net margin of 7.70%. Alcon's return on equity of 7.11% beat HCA Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HCA Healthcare	8.77%	-244.79%	11.10%
Alcon	7.70%	7.11%	4.98%

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, HCA Healthcare had 19 more articles in the media than Alcon. MarketBeat recorded 21 mentions for HCA Healthcare and 2 mentions for Alcon. HCA Healthcare's average media sentiment score of 0.76 beat Alcon's score of 0.53 indicating that HCA Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HCA Healthcare	12 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Alcon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

HCA Healthcare currently has a consensus target price of $465.59, indicating a potential upside of 12.63%. Alcon has a consensus target price of $84.76, indicating a potential upside of 20.96%. Given Alcon's stronger consensus rating and higher possible upside, analysts plainly believe Alcon is more favorable than HCA Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HCA Healthcare	1 Sell rating(s)	8 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.57
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HCA Healthcare	$75.60B	1.18	$6.78B	$29.87	13.84
Alcon	$10.40B	3.33	$980M	$1.66	42.21

HCA Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Alcon has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Summary

HCA Healthcare beats Alcon on 10 of the 17 factors compared between the two stocks.

How does Alcon compare to Tenet Healthcare?

Alcon (NYSE:ALC) and Tenet Healthcare (NYSE:THC) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Alcon has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Tenet Healthcare has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market.

Alcon presently has a consensus target price of $84.76, suggesting a potential upside of 20.96%. Tenet Healthcare has a consensus target price of $271.00, suggesting a potential upside of 3.18%. Given Alcon's higher probable upside, research analysts clearly believe Alcon is more favorable than Tenet Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
Tenet Healthcare	0 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.85

Tenet Healthcare has a net margin of 10.27% compared to Alcon's net margin of 7.70%. Tenet Healthcare's return on equity of 26.76% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
Tenet Healthcare	10.27%	26.76%	5.55%

53.9% of Alcon shares are held by institutional investors. Comparatively, 95.4% of Tenet Healthcare shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 1.0% of Tenet Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Tenet Healthcare had 10 more articles in the media than Alcon. MarketBeat recorded 12 mentions for Tenet Healthcare and 2 mentions for Alcon. Tenet Healthcare's average media sentiment score of 0.90 beat Alcon's score of 0.53 indicating that Tenet Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tenet Healthcare	9 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.33	$980M	$1.66	42.21
Tenet Healthcare	$22.64B	1.00	$1.41B	$25.93	10.13

Summary

Tenet Healthcare beats Alcon on 12 of the 17 factors compared between the two stocks.

How does Alcon compare to Encompass Health?

Encompass Health (NYSE:EHC) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	$6.07B	2.02	$566.20M	$5.99	20.59
Alcon	$10.40B	3.33	$980M	$1.66	42.21

97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by company insiders. Comparatively, 1.5% of Alcon shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Encompass Health has a net margin of 10.04% compared to Alcon's net margin of 7.70%. Encompass Health's return on equity of 18.28% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Encompass Health	10.04%	18.28%	8.27%
Alcon	7.70%	7.11%	4.98%

Encompass Health presently has a consensus price target of $144.43, indicating a potential upside of 17.12%. Alcon has a consensus price target of $84.76, indicating a potential upside of 20.96%. Given Alcon's higher probable upside, analysts clearly believe Alcon is more favorable than Encompass Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

In the previous week, Encompass Health had 9 more articles in the media than Alcon. MarketBeat recorded 11 mentions for Encompass Health and 2 mentions for Alcon. Encompass Health's average media sentiment score of 1.10 beat Alcon's score of 0.53 indicating that Encompass Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Encompass Health	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Encompass Health has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, Alcon has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Summary

Encompass Health beats Alcon on 9 of the 16 factors compared between the two stocks.

Get Alcon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALC vs. The Competition

Export

Metric	Alcon	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$34.61B	$5.79B	$6.86B	$24.08B
Dividend Yield	N/A	1.78%	2.60%	3.70%
P/E Ratio	42.16	23.49	280.40	32.26
Price / Sales	3.33	58.79	558.43	81.22
Price / Cash	12.95	32.67	71.79	32.38
Price / Book	1.57	6.12	12.95	6.92
Net Income	$980M	$151.74M	$3.49B	$1.07B
7 Day Performance	0.64%	3.54%	2.42%	2.10%
1 Month Performance	2.63%	-1.60%	-2.86%	1.67%
1 Year Performance	-16.69%	8.98%	75.31%	19.52%

Alcon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALC Alcon	3.6007 of 5 stars	$70.07 -0.7%	$84.76 +21.0%	-17.5%	$34.61B	$10.40B	42.16	25,942	Upcoming Earnings
COO Cooper Companies	3.0549 of 5 stars	$70.29 0.0%	$81.85 +16.4%	+7.6%	$13.71B	$4.23B	59.57	15,000	Positive News
DXCM DexCom	4.0583 of 5 stars	$73.37 +2.6%	$85.36 +16.3%	+9.5%	$27.61B	$4.66B	31.35	11,000	Positive News Earnings Report Analyst Forecast Insider Trade
HCA HCA Healthcare	4.5232 of 5 stars	$389.74 +2.0%	$473.36 +21.5%	+12.6%	$84.78B	$75.60B	13.05	320,000	Analyst Forecast
THC Tenet Healthcare	3.8863 of 5 stars	$242.42 +4.0%	$257.90 +6.4%	+63.6%	$20.09B	$22.64B	9.35	99,000	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ALC) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Summary

How does Alcon compare to DexCom?

Summary

How does Alcon compare to HCA Healthcare?

Summary

How does Alcon compare to Tenet Healthcare?

Summary

How does Alcon compare to Encompass Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Which has more risk and volatility, COO or ALC?

Which has preferable earnings and valuation, COO or ALC?

Is COO or ALC more profitable?

Do analysts recommend COO or ALC?

Do insiders & institutionals hold more shares of COO or ALC?

Does the media prefer COO or ALC?

Summary

How does Alcon compare to DexCom?

Which has more volatility and risk, ALC or DXCM?

Is ALC or DXCM more profitable?

Do institutionals & insiders believe in ALC or DXCM?

Do analysts rate ALC or DXCM?

Does the media favor ALC or DXCM?

Which has higher valuation and earnings, ALC or DXCM?

Summary

How does Alcon compare to HCA Healthcare?

Is HCA or ALC more profitable?

Do insiders & institutionals believe in HCA or ALC?

Does the media refer more to HCA or ALC?

Do analysts prefer HCA or ALC?

Which has stronger earnings & valuation, HCA or ALC?

Which has more volatility & risk, HCA or ALC?

Summary

How does Alcon compare to Tenet Healthcare?

Which has more risk and volatility, ALC or THC?

Do analysts recommend ALC or THC?

Is ALC or THC more profitable?

Do insiders & institutionals hold more shares of ALC or THC?

Does the media refer more to ALC or THC?

Which has better earnings & valuation, ALC or THC?

Summary

How does Alcon compare to Encompass Health?

Which has better earnings & valuation, EHC or ALC?

Do institutionals & insiders have more ownership in EHC or ALC?

Is EHC or ALC more profitable?

Do analysts rate EHC or ALC?

Does the media refer more to EHC or ALC?

Which has more risk and volatility, EHC or ALC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools